Table 2 Comorbidities and factors associated with neurological listeriosis - Univariate logistic analysis

Monotherapy (n = 57)

11

42.3

23

71.9

0.31

0.10-0.93**

Male

14

48.3

20

57.1

0.70

0.26-1.88

Saint Luc hospital

23

79.3

29

82.9

0.79

0.27-2.79

Diabetes mellitus

2

6.9

6

17.1

0.36

0.07-1.93

Immunosuppressive therapy

12

41.4

22

62.9

0.42

0.15-1.14

Cancer

11

37.9

11

31.4

1.33

0.47-3.76

Alcoholism

1

3.4

2

5.7

0.59

0.05-6.85

Renal disease

4

13.8

13

37.1

0.27

0.08-0.95**

HIV infection

2

6.9

4

11.4

0.57

0.10-3.38

Transplantation

3

10.3

9

25.7

0.33

0.08-1.37

Severe cardiovascular disease

6

20.7

13

37.1

0.44

0.14-1.37

Hepatic disease

3

10.3

8

22.9

0.40

0.09-1.63

Auto-immune disease

1

3.4

4

11.4

0.28

0.03-2.63

Immunocompromised status

16

55.2

25

71.4

0.49

0.18-1.38

Mean

SD

Mean

SD

OR

95 % CI

Age in years at admission

57.6

19.5

60.6

19.1

0.99

0.97-1.02

BMI (n = 33)

23.6

5.6

24.8

5.3

0.96

0.83-1.10

Systole at admission (mmHg) (n = 55)

129.2

32.9

123.3

30.2

1.01

0.99-1.03

Diastole at admission (mmHg)

75.0

12.1

70.8

19.1

1.02

0.98-1.05

% neutrophil in blood at admission (n = 41)

74.1

25.3

74.0

19.1

1.00

0.97-1.03

% lymphocytes in blood at admission (n = 37)

15.5

17.6

14.0

9.3

1.01

0.96-1.06

CRP mg/dl at admission (n = 47)

31.9

33.5

34.2

18.3

0.10

0.99-1.01

Creatinine in blood at admission mg/L (n = 60)

2.8

3.0

4.6

9.9

0.96

0.86-1.06

Blood platelets at admission/L (10³) (n = 56)

209.8

95.4

254.8

372.0

1.00

0.99-1.00

Median

Range

Median

Range

OR

95 % CI

% neutrophil in CSF (n = 20)

71.5

35.0-94.0

79.0

8.5-94.6

1.00

0.96-1.04

% lymphocytes in CSF (n = 8)

40.0

2.0-88.0

/

/

/

/

Glucose in CSF (mg/dL) (n = 10)

31.0

0.4-74.0

/

/

/

/

Protein in CSF (mg/L) (n = 14)

164.5

27.0-732.0

/

/

/

/

Admission year

1998

1983-2013

2006

1978-2014

0.95

0.90-1.02